Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02278120
Title Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (MONALEESA-7)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals

Her2-receptor negative breast cancer


Goserelin + Ribociclib + Tamoxifen

Goserelin + Tamoxifen

Anastrozole + Goserelin

Goserelin + Letrozole

Goserelin + Letrozole + Ribociclib

Anastrozole + Goserelin + Ribociclib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

No variant requirements are available.